title: Drug pricing, AIDS and the developing nations.
abstract: As world attention shifts to the problems of AIDS in Africa and other developing nations, it is clear that we need something other than "business as usual" if HIV-infected people are ever going to have access to treatment. The North American and European model, which relies on annual expenditures of ten to twenty thousand dollars a year per person for drugs and support services, will never meet the needs of countries that spend only a few dollars per person annually on health care. It is against this backdrop that world attention has begun to search for ways to stop or at least show the growing death rate from AIDS.
mesh_terms: D000163:Acquired Immunodeficiency Syndrome / Q000188:drug therapy*; D000349:Africa; D019380:Anti-HIV Agents / Q000191:economics*; D003906:Developing Countries; D016527:Drug Costs; D006801:Humans
chemical_list: D019380:Anti-HIV Agents